The Boston Scientific Lotus TAVR Valve

May 25, 2017 — Positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program, in Paris, demonstrated that the Boston Scientific Lotus Valve System, a transcatheter aortic valve implantation (TAVI) system, showed superiority over the Medtronic CoreValve TAVR System platform for the primary effectiveness endpoint and non-inferiority for the primary safety endpoint.

The May/June digital edition of Diagnostic and Interventional Cardiology (DAIC) is now available at http://editiondigital.net/publication/?i=409043&ver=html5&p=1#{"page":0,"issue_id":409043}

If you know an industry member who would also like to sign up for a free one-year subscription, please forward this link: https://www.cdsreportnow.com/renew?dic

Fourteen members of the Society of Interventional Radiology (SIR) took to Capitol Hill recently to express the society’s support for a bill that would expand access to government-funded graduate medical education (GME) opportunities to newly recognized primary specialties, including interventional radiology.

May 24, 2017 — Late-breaking data presented at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter aortic valve replacement (TAVR) patients treated with the new self-expanding Edwards Lifesciences’ Centera valve. These new 30-day results are the first data presented on the self-expanding Edwards Centera valve.

May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces the risk of all-cause mortality in ICD patients after one year by 38 percent. The TRUECOIN study also found a 36 percent reduction in the combined risk of all-cause mortality and hospitalization for worsening heart failure.[1]

W. L. Gore & Associates (Gore) announced positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech Republic. Gore plans to submit the positive data to the U.S. Food and Drug Administration (FDA) to seek a PFO indication for the Gore Cardioform Septal Occluder by year-end 2017.

May 24, 2017 — Philips recently announced the results from a global study indicating that automated three-dimensional echocardiographic (3DE) analysis of left-heart chambers is an accurate alternative to conventional manual methodology. This multicenter study assessed Philips HeartModel A.I.

Death in patients with heart failure is inversely related to the wealth of the country they live in, according to late breaking results from the INTERCHF study presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France. Death rates in India and Africa were three to four times higher than those documented in Western countries.

May 23, 2017 — The American Society of Echocardiography (ASE) will host its 28th Annual Scientific Sessions, June 2-6, 2017, at the Baltimore Convention Center. The program includes learning opportunities from the basics of clinical imaging, to the most sophisticated advances in microbubble gene delivery, to the determination of the best use of echocardiography in value-driven healthcare. The aim is to translate core concepts and new ideas into applicable frameworks.

Shockwave Medical announced last week CE Mark for the company’s Coronary Lithoplasty System for the treatment of calcified plaque in conjunction with stenting in patients with coronary artery disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now